|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of Minnesota - Clinical and Translational Science Institute |
|---|---|
| Collaborators: |
Endocare, Inc. Manoj, Monga, M.D. |
| Information provided by: | University of Minnesota - Clinical and Translational Science Institute |
| ClinicalTrials.gov Identifier: | NCT00177125 |
Purpose
The purpose of this study is to perform a randomized prospective study to evaluate whether the vacuum erection device facilitates an earlier return of erectile function post radical prostatectomy. A secondary measure will be to evaluate if the vacuum erection device can help prevent penile shortening.
| Condition | Intervention | Phase |
|---|---|---|
|
Prostatic Neoplasms Prostatectomy |
Device: ErectAid |
Phase III |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
| Official Title: | Evaluating the Effect of the Vacuum Constriction Device on Erectile Function and Penile Length Post Radical Retropubic Prostatectomy |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Minnesota | |
| University of Minnesota | |
| Minneapolis, Minnesota, United States, 55455 | |
| VAMC Minneapolis | |
| Minneapolis, Minnesota, United States, 55417 | |
| Principal Investigator: | Manoj Monga, MD | University of Minnesota and VAMC Minneapolis |
More Information
| Study ID Numbers: | 0406M61241, 3358B |
| Study First Received: | September 13, 2005 |
| Last Updated: | May 30, 2007 |
| ClinicalTrials.gov Identifier: | NCT00177125 History of Changes |
| Health Authority: | United States: Institutional Review Board |
|
Neoplasms Neoplasms by Site Prostatic Diseases Genital Neoplasms, Male |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |